Key Events This Week
16 Mar: Stock hits 52-week low at Rs.101.15 amid sector pressures
20 Mar: Valuation shifts to fair grade as price rises to Rs.119.65
May 08
BSE+NSE Vol: 1.49 k

Vasundhara Rasayans Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 Dec 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 08 May 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article
Vasundhara Rasayans Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 17 December 2025, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics presented here are based on the company’s current position as of 22 April 2026, providing investors with the latest insights into its performance and prospects.
Read full news article
Vasundhara Rasayans Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 Dec 2025. However, the analysis and financial metrics presented here reflect the stock's current position as of 09 April 2026, providing investors with an up-to-date view of its fundamentals, returns, and market performance.
Read full news article
Vasundhara Rasayans Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its valuation parameters, moving from an attractive to a fair valuation grade. Despite a robust day gain of 9.33%, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now reflect a more tempered market enthusiasm compared to its historical averages and peer benchmarks. This article analyses the implications of these valuation changes in the context of the company’s financial metrics, sector dynamics, and relative performance against peers and the broader market.
Read full news article
16 Mar: Stock hits 52-week low at Rs.101.15 amid sector pressures
20 Mar: Valuation shifts to fair grade as price rises to Rs.119.65

Vasundhara Rasayans Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 Dec 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 20 March 2026, providing investors with the latest insights into the stock’s performance and outlook.
Read full news article
Vasundhara Rasayans Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its valuation parameters, moving from an attractive to a fair valuation grade. This change reflects evolving market perceptions amid a challenging price performance and a competitive peer landscape. Investors are advised to carefully analyse the company’s current price-to-earnings (P/E) and price-to-book value (P/BV) ratios in relation to historical averages and sector benchmarks to assess its price attractiveness.
Read full news article
Vasundhara Rasayans Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, touched a new 52-week low of Rs.101.15 today, marking a significant decline amid a volatile trading session. The stock’s performance continues to lag behind broader market indices and sector peers, reflecting ongoing pressures on its financial metrics and market positioning.
Read full news articleCertificate as per Reg 74(5) of the SEBI (DP) Reg 2018 for the quarter ended on 31.03.2026
Trading window for dealing in Shares of Vasundhara Rasayans Limited shall remain closed from 1st April 2026 till 48 hours after the declaration of financial Results for the qaurter and Financial year ended 31.03.2026
Communication from the lessor extending the effective date of termination of the manufacturing facility from 31.03.2026 to 30.04.2026
No Upcoming Board Meetings
Vasundhara Rasayans Ltd has declared 20% dividend, ex-date: 19 Sep 25
No Splits history available
No Bonus history available
No Rights history available